Apple acquires brain imaging firm for health and accessibility features
AI-summarised brief · reviewed before publication
Apple has acquired Sonera, a California-based firm specializing in non-invasive neural signal sensors, according to the European Union’s acquisition database. The deal, finalized in May 2026, remains unannounced by Apple, though Sonera’s website has been removed. Founded in 2018 by UC Berkeley students Nishita Deka and Dominic Labanowski, Sonera emerged from stealth in 2023 with $11 million in financing. The company’s S1 chip detects magnetic muscle activity, offering a portable, affordable alternative to electrical sensors that are often dampened by the skull. This technology enables thought-controlled device interaction without surgical implants, contrasting with current Apple Vision Pro methods requiring head implants. Potential applications include controlling prosthetics and integrating into consumer wearables like the Apple Watch for continuous neuromuscular condition monitoring. Sonera’s focus on high-performance, direct brain activity imaging aligns with Apple’s expanding health and accessibility initiatives, suggesting a strategic move toward advanced, non-invasive biometric tracking capabilities for future product lines.
💡 Why It Matters
- · This acquisition eliminates the need for invasive implants to achieve precise thought-controlled device interaction.
- · It positions Apple to integrate advanced neuromuscular monitoring directly into mainstream wearables like the Apple Watch.
